This week’s cover story is a careful dissection of the information given to women who are about to undergo breast screening with mammography (doi:10.1136/bmj.b86). Three years ago Jørgensen and Gøtzsche surveyed information given to women invited for breast screening in six countries and concluded that all of it was misleading—because it didn’t mention the major harm of misdiagnosis and overtreatment (BMJ 2006;332:538). This week they and their colleagues revisit the issue—by explaining how the leaflet used in the United Kingdom still misleads. Gøtzsche and his colleagues are known critics of breast screening programmes, having long argued that their benefits are small and their …